Covered recipient · General Payments record
PETER R KASTL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$17,689.68
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,825.78 | 16 |
| Food and Beverage | $218.86 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $15,825.78 | 16 |
| GLAUKOS CORPORATION | $218.86 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Plasma Inc. | $1,185.64 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134625469 | CMS |
| CSL Plasma Inc. | $1,128.14 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134625471 | CMS |
| CSL Plasma Inc. | $1,070.64 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134625473 | CMS |
| CSL Plasma Inc. | $1,185.64 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134625475 | CMS |
| CSL Plasma Inc. | $1,236.98 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142134990 | CMS |
| CSL Plasma Inc. | $1,236.98 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142134998 | CMS |
| CSL Plasma Inc. | $1,236.98 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135000 | CMS |
| CSL Plasma Inc. | $1,294.48 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135008 | CMS |
| CSL Plasma Inc. | $1,179.48 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135016 | CMS |
| CSL Plasma Inc. | $1,121.98 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135022 | CMS |
| CSL Plasma Inc. | $1,151.46 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135026 | CMS |
| CSL Plasma Inc. | $776.98 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135034 | CMS |
| CSL Plasma Inc. | $535.46 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135036 | CMS |
| CSL Plasma Inc. | $532.24 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135042 | CMS |
| CSL Plasma Inc. | $477.96 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135044 | CMS |
| CSL Plasma Inc. | $474.74 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142135048 | CMS |
| Glaukos Corporation | $56.30 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988506 | CMS |
| Glaukos Corporation | $34.24 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988504 | CMS |
| Glaukos Corporation | $128.32 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151976778 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.